Trial Profile
Phase I trial of controlled-release ropivacaine for postoperative pain.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2014
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Heron Therapeutics
- 30 Apr 2014 New trial record